PLK1 and cancer: PLK1 expression is increased in several types of cancers including urothelial carcinoma of bladder [16], renal cancer [17], breast cancer [18], prostate cancer [19], neuroblastoma [20], hepatocellular carcinoma [21], cervical carcinoma [22], and non-melanoma skin cancers [23].